• MJHLS Brand Logo

© 2025 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Practice

European Drug Agency's Move Out of London, Spurred By Brexit, Could Disrupt Pipeline

April 6th 2017

By Christina Mattina

Article

Nominee for FDA Commissioner Vows to Strike Balance Before Senate Panel

April 6th 2017

By Jackie Syrop

Article

Biologics Superior for Relief of IBD Symptoms and Maintenance of Intestinal Health

April 5th 2017

By Jackie Syrop

Article

NHS May Use More "Stick" Than "Carrot" to Ensure Prescribing of Cheaper Biosimilars

March 28th 2017

By Jackie Syrop

Article

Policy Briefing Calls for More Efficient Biosimilar Approval Process

March 27th 2017

By Jackie Syrop

Article

Amgen Gains EC Approval for Biosimilar to Adalimumab

March 24th 2017

By Surabhi Dangi-Garimella, PhD

Article

Payer Cost Savings From Filgrastim Biosimilars Could Reach $2 Million Annually

March 23rd 2017

By Christina Mattina

Article

New Lawsuit Concerning Insulin Price-Fixing Filed in Federal Court

March 22nd 2017

By Jackie Syrop

Article

Infographic: Biosimilar Substitution Laws By State

March 21st 2017

By Christina Mattina

Article

Omalizumab Biologic is Changing the Face of Asthma Therapeutics

March 20th 2017

By The Center for Biosimilars Staff

Article